Of them, transforming growth factor-beta-induced protein (TGFBI), as an extracellular matrix (ECM) protein, has indicated a critical role in tumor progression, angiogenesis21, and sensitivity of 5-Fluorouacil based chemotherapy in CRC22,23. The gene discussed is TGFBI; the disease is neoplasm.